King's College London

Research portal

Meeting the challenge of antimicrobial resistance in cirrhosis: the invisible threat that lies within

Research output: Contribution to journalEditorialpeer-review

Original languageEnglish
Pages (from-to)413-415
Number of pages3
JournalGastroenterology
Volume161
Issue number2
Early online date25 May 2021
DOIs
E-pub ahead of print25 May 2021
PublishedAug 2021

Bibliographical note

Funding Information: Conflicts of interest The authors have made the following disclosures: Dr Goldenberg has participated in consultancy and advisory boards for Astellas, Enterobiotix, Menarini, MSD, Pfizer and Shionogi and has an investigator-initiated study funded by Shionogi. Professor Shawcross has participated in consultancy and advisory boards for EnteroBiotix, Norgine Pharmaceuticals Ltd, Kaleido Biosciences, Mallinckrodt and Shionogi and has delivered paid lectures for Norgine Pharmaceuticals Ltd, Falk Pharma and Alfa Sigma. Professor Shawcross has an investigator-initiated study funded by Norgine Pharmaceuticals Ltd. Funding Information: Conflicts of interest The authors have made the following disclosures: Dr Goldenberg has participated in consultancy and advisory boards for Astellas, Enterobiotix, Menarini, MSD, Pfizer and Shionogi and has an investigator-initiated study funded by Shionogi. Professor Shawcross has participated in consultancy and advisory boards for EnteroBiotix, Norgine Pharmaceuticals Ltd, Kaleido Biosciences, Mallinckrodt and Shionogi and has delivered paid lectures for Norgine Pharmaceuticals Ltd, Falk Pharma and Alfa Sigma. Professor Shawcross has an investigator-initiated study funded by Norgine Pharmaceuticals Ltd. Copyright: Copyright 2021 Elsevier B.V., All rights reserved.

King's Authors

View graph of relations

© 2020 King's College London | Strand | London WC2R 2LS | England | United Kingdom | Tel +44 (0)20 7836 5454